World health

Long-term Coflex and spinal-fusion study posts registry results

ClinicalTrials.gov reports results from a completed post-approval study comparing Coflex with fusion for lumbar spinal stenosis.

14 Sept 20261 min read

Medical TechnologyBreaking

Dual-MRI study in people with long COVID posts registry results

A completed Phase 2 study used dual MRI to investigate cardiopulmonary findings in people with persistent symptoms after COVID-19.

14 Sept 20261 min read

AI & Healthcare

Registry posts results from neurofeedback-enhanced mindfulness study

ClinicalTrials.gov has posted results from a completed study of neurofeedback-enhanced mindfulness in traumatic brain injury.

14 Sept 20261 min read

Research & Studies

ClinicalTrials.gov reports pharmacokinetic results for apremilast study

A completed Phase 1 study in 28 healthy Korean men reports pharmacokinetic measurements for single and repeated doses of apremilast.

14 Sept 20261 min read

Research & Studies

ClinicalTrials.gov posts results from montelukast study in smokers with asthma

ClinicalTrials.gov has posted results from a completed Phase 4 study evaluating treatment approaches in smokers with asthma.

14 Sept 20261 min read

PharmaceuticalsBreaking

MHRA safety alert: Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide hydrochloride 2 mg Orodispersible

The UK regulator has issued a safety notice concerning Class 4 Medicines Defect Notification, with guidance for affected healthcare services.

14 Sept 20261 min read

MHRA safety alert: Class 4 Medicines Defect Notification: Fresenius Medical Care Deutschland GmbH, balance 2.3% glucose,

The UK regulator has issued a safety notice concerning Class 4 Medicines Defect Notification, with guidance for affected healthcare services.

14 Sept 20261 min read

MHRA safety alert: Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi (Denosumab) 60mg Solution for Injection

The UK regulator has issued a safety notice concerning Class 4 Medicines Defect Notification, with guidance for affected healthcare services.

14 Sept 20261 min read

MHRA safety alert: Class 4 Medicines Defect Notification: Cadila Pharmaceuticals Limited, Mirtazapine 30mg Tablets, EL(2

The UK regulator has issued a safety notice concerning Class 4 Medicines Defect Notification, with guidance for affected healthcare services.

14 Sept 20261 min read

MHRA safety alert: Class 3 Medicines Recall: Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml Solution for injection, EL

The UK regulator has issued a safety notice concerning Class 3 Medicines Recall, with guidance for affected healthcare services.

14 Sept 20261 min read

MHRA safety alert: Class 4 Medicines Defect Notification: Brancaster Pharma Limited, Benzylpenicillin benzathine 1.2 Mil

The UK regulator has issued a safety notice concerning Class 4 Medicines Defect Notification, with guidance for affected healthcare services.

14 Sept 20261 min read

MHRA safety alert: Class 3 Medicines Recall: Flamingo Pharma UK Ltd, Flucloxacillin Capsules BP 500mg, EL(26)A/32

The UK regulator has issued a safety notice concerning Class 3 Medicines Recall, with guidance for affected healthcare services.

14 Sept 20261 min read

MHRA safety alert: Class 4 Medicines Defect Notification: Relonchem Limited, Gabapentin Relonchem 50mg/ml Oral Solution,

The UK regulator has issued a safety notice concerning UPDATE, with guidance for affected healthcare services.

14 Sept 20261 min read

MHRA safety alert: Class 2 Medicines Recall: Bristol Laboratories Limited, Phenoxymethylpenicillin 250 mg/5ml Sugar free

The UK regulator has issued a safety notice concerning Class 2 Medicines Recall, with guidance for affected healthcare services.

14 Sept 20261 min read

MHRA safety alert: Class 2 Medicines Recall: Beckton Dickson UK Ltd, ChloraPrep 1mL applicator, EL(26)A/34

The UK regulator has issued a safety notice concerning Class 2 Medicines Recall, with guidance for affected healthcare services.

14 Sept 20261 min read

MHRA safety alert: Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL

The UK regulator has issued a safety notice concerning Class 4 Medicines Defect Notification, with guidance for affected healthcare services.

14 Sept 20261 min read

MHRA safety alert: Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets

The UK regulator has issued a safety notice concerning Class 4 Medicines Defect Notification, with guidance for affected healthcare services.

14 Sept 20261 min read

MHRA safety alert: Dräger Atlan Anaesthesia workstations: risk of ventilator failure (DSI/2026/005)

The UK regulator has issued a safety notice concerning Dräger Atlan Anaesthesia workstations, with guidance for affected healthcare services.

14 Sept 20261 min read

MHRA Warns Wrong Infusion Set Can Cause Severe Harm During Transfusion

Using a standard IV infusion set instead of a blood-transfusion set may under-deliver blood or destroy red cells, potentially causing serious injury.

14 Sept 20261 min read

UK Updates Safety Guidance on Namic Syringes and Manifolds

Affected components in Kimal procedure packs carry risks of syringe disconnection or foreign particles and should be used only for urgent procedures when no alternative exists.

14 Sept 20261 min read

Safety Advice Updated for Allurion Gastric Balloon

Rare cases in which the balloon did not pass as intended have led to gastric outlet or bowel obstruction and gastric perforation, requiring prompt assessment.

14 Sept 20261 min read

Ramipril 2.5 mg Batch Recalled After 10 mg Blisters Found in Pack

A sealed 2.5 mg carton from batch GR155023 contained two 10 mg blister packs, creating a risk of unintentional overdose, the UK regulator says.

14 Sept 20261 min read

UK Recalls ChloraPrep Applicators Over Potential Sterility Breach

The recall covers specified 1 mL and 1.5 mL applicators after a packaging-process issue that could allow pathogen contamination and raise infection risk.

14 Sept 20261 min read

MHRA Updates Safety Advice for Belzer Organ-Preservation Solutions

Corrective action has allowed UK sales to resume, but transplant teams are told to inspect every bag for leakage, discoloration, particles or contamination before use.

14 Sept 20261 min read

MHRA Orders Quarantine of Medical Devices Without Valid Conformity Marks

The regulator says specified devices lack valid UKCA or CE conformity evidence, so assurance of safety, sterility and performance cannot be fully guaranteed.

14 Sept 20261 min read

UK Issues Patient Safety Alert for ResMed Astral Ventilators

A circuit-board fault can unexpectedly stop ventilation in Astral 100 and 150 devices made before October 2024, requiring immediate access to alternative ventilation.

14 Sept 20261 min read

UK Recalls One Batch of Fingolimod Zentiva Capsules

Batch 4L01372H is being recalled over possible small metal particles found during shelf-life testing; the MHRA says no harm reports had been received.

14 Sept 20261 min read

MHRA Says Personal-Use Rectal Catheters Should Not Be Used in Infants

The regulator cites insufficient evidence of benefit and unknown risks, including possible trauma, bleeding, pain or perforation, for products sold as gas and colic relievers.

14 Sept 20261 min read

UK Orders Withdrawal of NGPod pH Testing Devices

Users should stop using and dispose of NGPod devices after earlier incidents included a misplaced nasogastric tube and one fatal outcome, the MHRA says.

14 Sept 20261 min read